IL17A and epilepsy: Ouédraogo et al. identified that CD4+ T cells along with pro-inflammatory cytokines (e.g., interleukin-17A and tumor necrosis factor) expressed by CD4+ T cells were elevated in the peripheral blood of patients with drug-resistant epilepsy compared with that in patients with well-controlled epilepsy (21).